Thomas Spitznagel
Net worth: 142 224 $ as of 2026-07-30
Net worth: 142 224 $ as of 2026-07-30
Thomas M.
Spitznagel is Senior Vice President-Technical Operations at MacroGenics, Inc. since 2013.
Formerly, Senior Scientist at Nabi Biopharmaceuticals from 1996 to 1998, Vice President-BioPharmaceutical Development at Human Genome Sciences, Inc. from 1998 to 2012, and Staff Engineer at Genetics Institute LLC in 1996.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from the University of California, Berkeley.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MACROGENICS, INC. 0.06% | 2026-02-14 | 38,543 ( 0.06% ) | 142 224 $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| MACROGENICS, INC. | Chief Tech/Sci/R&D Officer | 2012-12-31 |
| Companies | Position | End |
|---|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | 2012-06-30 |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Chief Tech/Sci/R&D Officer | 1997-12-31 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 1995-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
MacroGenics, Inc.
MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions